Levetiracetam
Product Images NDC 50090-2815

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-2815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (7316b619 C812 4279 8c99 1105f0ff3508 01)

FDA Label Image

Fig 1 (7316b619 C812 4279 8c99 1105f0ff3508 02)

FDA Label Image

Fig 2 (7316b619 C812 4279 8c99 1105f0ff3508 03)

Fig 2 (7316b619 C812 4279 8c99 1105f0ff3508 03)
This table represents the percentage of patients in a clinical trial receiving different doses of Levetiracetam compared to a placebo. The doses tested were 1000 mg/day and 2000 mg/day. There were 111 patients who received the placebo, 106 patients who received the 1000mg/day dose of Levetiracetam and 105 patients who received the 2000mg/day dose of Levetiracetam. The percentages indicate the portion of patients who received each treatment, but the purpose of the study or other results are not provided in the text.*
FDA Label Image

Fig 3 (7316b619 C812 4279 8c99 1105f0ff3508 04)

FDA Label Image

Fig 4 (7316b619 C812 4279 8c99 1105f0ff3508 05)

Fig 4 (7316b619 C812 4279 8c99 1105f0ff3508 05)
This appears to be a table showing the percentages of patients in a medical study who were either on a placebo or taking a medication called Levetiracetam. The percentages range from 20% to 45%, but there is not enough information to determine what the percentage represents. The table also includes symbols such as %, @, and ®.*
FDA Label Image

5 (7316b619 C812 4279 8c99 1105f0ff3508 06)

FDA Label Image

Fig 6 (7316b619 C812 4279 8c99 1105f0ff3508 07)

Fig 6 (7316b619 C812 4279 8c99 1105f0ff3508 07)
This appears to be a part of a statistical presentation, showing the percentage of patients in a placebo group and a group treated with Levetiracetam. However, without additional information or context, it is not possible to determine the purpose of this presentation or the significance of the numbers provided.*
FDA Label Image

Logo (7316b619 C812 4279 8c99 1105f0ff3508 08)

FDA Label Image

Logo (7316b619 C812 4279 8c99 1105f0ff3508 09)

FDA Label Image

Label Image (Lbl500902815)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.